Importance Remdesivir demonstrated clinical benefit in a placebo-controlled trial in patients
with severe coronavirus disease 2019 (COVID-19), but its effect in patients with moderate …

Background People living with HIV have accounted for 38–50% of those affected in the 2022
multicountry mpox outbreak. Most reported cases were in people who had high CD4 cell …

Background: In patients who have symptomatic deep venous thrombosis, the long-term risk
for recurrent venous thromboembolism and the incidence and severity of post-thrombotic …

Background Effective two-drug regimens could decrease long-term drug exposure and toxicity
with HIV-1 antiretroviral therapy (ART). We therefore aimed to evaluate the efficacy and …

Background. In contrast to the established relation between overt cancer and subsequent
venous thromboembolism, it is unclear whether symptomatic deep-vein thrombosis is …

Aims We investigated whether pre-existing diabetes, newly-diagnosed diabetes, and admission
hyperglycemia were associated with COVID-19 severity independently from confounders…

Background While acute kidney injury (AKI) is a common complication in COVID-19, data
on post-AKI kidney function recovery and the clinical factors associated with poor kidney …

Because other coronaviruses enter the cells by binding to dipeptidyl‐peptidase‐4 (DPP‐4),
it has been speculated that DPP‐4 inhibitors (DPP‐4is) may exert an activity against severe …

Background To improve our understanding of the natural history of Zika virus (ZIKV) infection
in humans, we described the dynamics of ZIKV RNA shedding in different body fluids and …

Since the outbreak of the COVID-19 epidemic which in our region, Veneto (Italy), dates back
to February, we were confronted with several challenges, but with a constant aim of keeping …